CSIMarket
 

Neovasc Inc   (NASDAQ: NVCN)

Neovasc Inc 's

Competitiveness




 

NVCN Sales vs. its Competitors Q4 2021



Comparing the current results to its competitors, Neovasc Inc reported Revenue increase in the 4 quarter 2021 by 0 % year on year.
The revenue growth was below Neovasc Inc 's competitors' average revenue growth of 153.78 %, achieved in the same quarter.

List of NVCN Competitors





Revenue Growth Comparisons




Net Income Comparison


Neovasc Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  NVCN Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Neovasc Inc




Titan Pharmaceuticals Inc
Share Performance



+44.52%
This Year



Titan Pharmaceuticals Inc
Profile

Titan Pharmaceuticals Inc is a biopharmaceutical company that operates through a licensing business model. They focus on the development and commercialization of proprietary therapeutics for the treatment of different diseases and disorders. By licensing their products to strategic partners, they aim to leverage their technology and expertise for the commercial success of their pharmaceuticals.

More about Titan Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4.910 mill. $ - mill. $ -2.805 mill.

Sources: Neovasc Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Neovasc Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.